NCT06944743

Brief Summary

The study is for aproved that Transurtheral Resection of prostate is good for patient with underactive bladder or not.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 25, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

March 23, 2025

Last Update Submit

April 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in international prostate symptome score (IPSS) score.

    Outcome measure Detrusar pressure at maximum flow (Pdet-Qmax unit:CmH2O)

    3 month .

Study Arms (1)

Transurtheral Resection of prostate in underactive bladder with bladder outlet obstruction

OTHER

TURP involves an endoscopic approach via the patient's urethra to surgically remove the inner portion of the prostate that encircles the urethra. A bipolar electrified wire loop is used to remove the portion of the prostate between the bladder neck and the verumontanum to a depth of the surgical capsule. Before the resection is begun, the bladder should be inspected for any bladder pathology (e.g., tumor, diverticula or stones). The bladder neck, trigone, and position of the ureteral orifices, verumontanum, and external sphincter should be noted. Three-way Foley catheter is usually placed to and traction for a short time, release of traction based on clearance of hematuria.

Procedure: Transurtheral Resection of prostate ( TURP)

Interventions

TURP involves an endoscopic approach via the patient's urethra to surgically remove the inner portion of the prostate that encircles the urethra. A bipolar electrified wire loop is used to remove the portion of the prostate between the bladder neck and the verumontanum to a depth of the surgical capsule. Before the resection is begun, the bladder should be inspected for any bladder pathology (e.g., tumor, diverticula or stones). The bladder neck, trigone, and position of the ureteral orifices, verumontanum, and external sphincter should be noted. Three-way Foley catheter is usually placed to and traction for a short time, release of traction based on clearance of hematuria.

Transurtheral Resection of prostate in underactive bladder with bladder outlet obstruction

Eligibility Criteria

Age40 Years - 70 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients diagnosed with BOO and UAB
  • Age ≥ 40 years.

You may not qualify if:

  • Patient insulin dependent diabetes
  • Patient with history of cerbrovascular stroke or hemarrage.
  • History of prior prostate surgery.
  • Urethral pathology or surgery.
  • Patient with prostate or bladder cancer.
  • Spinal and pelvic trauma or surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emad Abdellah Ali Mostafa

Sohag, 093, Egypt

RECRUITING

MeSH Terms

Conditions

Urinary RetentionProstatic Diseases

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesGenital Diseases, MaleGenital Diseases

Study Officials

  • Emad Mostafa, MD

    Assistant lecture

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director,Head of urology,Principal investigator,clinical professor

Study Record Dates

First Submitted

March 23, 2025

First Posted

April 25, 2025

Study Start

April 1, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 25, 2025

Record last verified: 2025-04

Locations